BackAmexdrug Overview

Amexdrug Receivables

Track Amexdrug's receivables ($37K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$37486.00
↓ 76.89% YoYΔ $-124744.00 vs prior year quarter

Peer trimmed avg / median

Loading

Amexdrug Receivables History

Loading

Amexdrug vs. peers: Receivables Comparison

Loading

Amexdrug Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Amexdrug (AXRX) FAQ

The latest receivables for AXRX is $37K as of March 2026. That compares with $160K in the prior-year period — down 76.9% year over year. Investors often review this figure alongside Amexdrug's historical trend and sector peers before judging valuation or financial health.

Over the past year, AXRX's receivables moved from $160K to $37K — a 76.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Amexdrug's operating scale or balance-sheet position.

A receivables figure of $37K for AXRX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting AXRX's receivables ($37K), review year-over-year change from $160K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.